Clinical efficacy of benazepril and irbesartan for children with chronic glomerulonephritis by LIU Xiao-yan

Subjects: Get full text

Dynamics of testosterone and prolactin levels, blood pressure and parameters of cardiovascular remodeling in hypertensive men with androgen deficiency in the course of treatment by V. A. Vizir, O. V. Nasonenko, A. S. Sadomov

Subjects: Get full text

Interaction between dipeptidyl-peptidase-4 inhibitors and drugs acting on renin angiotensin aldosterone system for the risk of angioedema: a pharmacovigilance assessment using disp... by Kannan Sridharan, Gowri Sivaramakrishnan

Subjects: Get full text

HPLC method with monolithic column for simultaneous determination of irbesartan and hydrochlorothiazide in tablets by Alanazi Amer M., Abdelhameed Ali S., Khalil Nasr Y., Khan Azmat A., Darwish Ibrahim A.

Subjects: “…irbesartan…”
Get full text

Seven New Irbesartan Salts: Significantly Improved Dissolution, Excellent Hygrothermal Stability, and Characteristic Supramolecular Synthons by Junxiao Wang, Chuanhua Wu, Menglong Zhang, Lingli Hou, Wei Chen, Dingding Jing, Ying Bao

Subjects: “…irbesartan…”
Get full text

Metabolic syndrome and angiotensin II receptor antagonists by K. M. Mamyrbayeva, V. B. Mychka, V. B. Sergienko, I. E. Chazova

Subjects: Get full text

Efficiency assessment for antihypertensive, hemodynamic, renal effects of adenosine-converting enzyme (ACE) inhibitors and irbesartan and impact on endothelial disfunction in patie... by M. V. Pereviazkina

Subjects: Get full text

IRBESARTAN IN THE CLINICAL PRACTICE by V. I. Podzolkov, A. I. Tarzimanova

Subjects: “…irbesartan…”
Get full text

Studies on jackfruit seed starch as a novel natural superdisintegrant for the design and evaluation of irbesartan fast dissolving tablets by Vidyadhara Suryadevara, Sasidhar Reddyvallam Lankapalli, Lakshmi Harika Danda, Vijetha Pendyala, Vijetha Katta

Subjects: Get full text

Effect of Irbesartan on TRPC6 expression in high glucose-induced mouse podocytes by HU Chun-li, XIE Xi-sheng, FENG Sheng-gang

Subjects: “…Irbesartan…”
Get full text

APPROACHES TO SELECTION OF ANTIHYPERTENSION DRUG WITHIN APPLIED LOWER TARGET BLOOD PRESSURE LEVELS by S. R. Gilyarevsky, М. V. Golshmid, I. М. Kuzmina

Subjects: Get full text

Life-threatening amlodipine and irbesartan poisoning in two adolescents: Extracorporeal life support is life-saving by Gülizar Koç, İrem Ersayoğlu, Kübra Cebeci, Sercan Çınarlı, Pınar Yazıcı Özkaya, Osman Nuri Tuncer, Bülent Karapınar

Subjects: Get full text

Left ventricular hypertrophy: prognostic value, pathogenesis, possible remodeling: focusing on angiotensin receptor antagonists by M. D. Smirnova, F. T. Ageev

Subjects: Get full text

Arterial hypertension and Type 2 diabetes mellitus: any benefits for angiotensin II receptor blockers? by V. V. Fomin, S. V. Moiseev, E. A. Saginova

Subjects: Get full text

The effect of the <i>M235T</i> polymorphism of the angiotensinogen gene on the office blood pressure during therapy with angiotensin II receptor blockers by E. V. Rebrova, E. V. Shikh

Subjects: Get full text

Evaluation of the relationship between the minimum steady-state concentration of angiotensin II receptor blockers and polymorphic markers of CYP2C9 (Arg144Cys), CYP2C9 (IlE359Leu),... by E. V. Rebrova, E. V. Shikh, V. V. Smirnov, G. S. Anikin, L. M. Ignatova, M. M. Bogdanov

Subjects: Get full text

SARTANS AND ANGIOTENSIN CONVERTING ENZYME INHIBITORS: A DUEL BETWEEN TWO LEADERS OF PHARMACOTHERAPY OF CARDIOVASCULAR DISEASES by K. A. Gyamdzhyan, M. L. Maksimov

Subjects: Get full text

Use of angiotensin receptor blockers in cardiovascular protection. Current evidence and future directions by M. A. Munger

Subjects: Get full text